Drugs / FluLaval
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT04484532 | Oct 2017 → Jun 2022 | acute myeloid leukemia, myelodysplastic syndrome | Roswell Park Cancer Institute | Completed | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT01059617 | Feb 2010 → Jan 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05170399 | Sep 2022 → Aug 2026 overdue | lymphoma | National Heart, Lung, and Blood Institute (NHLBI) | Recruiting | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 1 | NCT00858611 Background | Mar 2009 → Jun 2010 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1/2 | NCT01248208 Comparator | Sep 2010 → Sep 2011 | food allergy | Walter Reed Army Medical Center | Completed | No outcome recorded |
| — | NCT00902278 Comparator | Oct 2008 → Apr 2016 | — | University of Massachusetts, Worcester | Completed | No outcome recorded |
Press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2016-11-18 | GlaxoSmithKline | GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older gsk.com ↗ |
| 2016-02-02 | GlaxoSmithKline | GSK announces US regulatory submission seeking expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 mos+ gsk.com ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluLaval | “licensed 2008/2009 FluLaval(Registered Trademark)” NCT00858611 ↗ |
| Known as | GSK Biologicals' FluLaval | “GSK Biologicals' FluLaval®” NCT01059617 ↗ |
| Modality | Vaccine | “The inactivated seasonal influenza vaccine is the trivalent subunit virion vaccine for the 2008-2009 season” NCT00858611 ↗ |